Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer

Oncology Reports

Volumn 20, Issue 5, 2008, Pages 1125-1130

  Sasaki, Hidefumi ^a   Okuda, Katsuhiro ^a   Kawano, Osamu ^a   Yukiue, Haruhiro ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Arg388; FGFR4; Lung cancer; Mutations; Polymorphism

Indexed keywords

ARGININE; FIBROBLAST GROWTH FACTOR 4; GEFITINIB; PLATINUM COMPLEX; FIBROBLAST GROWTH FACTOR RECEPTOR 4;

ADULT; ADVANCED CANCER; ALLELE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CODON; CONTROLLED STUDY; FEMALE; GENDER; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; JAPANESE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; RECURRENT CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ASIAN; GENETIC POLYMORPHISM; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; MORTALITY; MUTATION; POLYMERASE CHAIN REACTION;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4;

EID: 58149340186     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000119     Document Type: Article

References (29)

1. Ginsberg RJ, Kris K and Armstrong G: Cancer of the lung. In: Principles and Practice of Oncology. 4th edition, Lippincott, Philadelphia, pp673-682, 1993.
2. Corder EH, Saunders AM, Risch NJ, et al: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7: 180-184, 1994.
3. Burke D, Wilkes D, Blundell TL and Malcolm S: Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci 23: 59-62, 1998.
4. Warburton D, Tefft D, Mailleux A, et al: Do lung remodeling, repair, and regeneration recapitulate respiratory ontogeny? Am J Respir Crit Care Med 164: S59-S62, 2001.
5. Nakamura N, Iijima T, Mase K, et al: Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue. Cancer Sci 95: 226-232, 2004.
6. Bange J, Prechtl D, Cheburkin Y, et al: Cancer progression and tumor cell motility are associated with the FGFR4 Arg388 allele. Cancer Res 62: 840-847, 2002.
7. Thussbas C, Nahrig J, Streit S, et al: FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. J Clin Oncol 24: 3747-3755, 2006.
8. Streit S, Bange J, Fichtner A, Ihrler S, Issing W and Ullrich A: Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma. Int J Cancer 111: 213-217, 2004.
9. Spinola M, Leoni V, Pignatiello C, et al: Functional FGFR4 Gly 388Arg polymorphism predicts prognosis in lung adeno-carcinoma patients. J Clin Oncol 23: 7307-7311, 2005.
10. Marks JL, McLellan MD, Zakowski MF, et al: Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4. Plos One 5: e426, 2007.
11. Japan Lung Cancer Society, General Rule for Clinical and Pathological Record of Lung Cancer. 5th edition, Kanehara Press, pp1-177, 1999.
12. Endo K, Konishi A, Sasaki H, et al: Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50: 375-384, 2005.
13. Sasaki H, Shimizu S, Endo K, et al: EGFR and erbB2 mutation status in Japanese lung cancer patients. Int J Cancer 118: 180-184, 2006.
14. Sasaki H, Endo K, Konishi A, et al: EGFR mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Clin Cancer Res 11: 2924-2929, 2005.
15. Eswarakumar VP, Lax I and Schlessinger J: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149, 2005.
16. Matsumoto-Yoshitomi S, Habashita J, Nomura C, Kuroshima K and Kurokawa T: Autocrine transformation by fibroblast growth factor 9 (FGF-9) and its possible participation in human oncogene. Int J Cancer 71: 442-450, 1997.
17. Leung HY, Gullick WJ and Lemoine NR: Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 59: 667-675, 1994.
18. Jaakkola S, Salmikangas P, Nylund S, et al: Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 54: 378-382, 1993.
19. Lehtola L, Partanen J, Sistonen L, et al: Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells. Int J Cancer 50: 598-603, 1992.
20. Takahashi A, Sasaki H, Kim SJ, et al: Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem Biophys Res Commun 257: 855-859, 1999.
21. Clark JC, Tichelaar JW, Wert SE, et al: FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am J Physiol Cell Mol Physiol 280: L705-L715, 2001.
22. Tichelaar J, Lu W and Whitsett J: Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J Biol Chem 275: 11858-11864, 2000.
23. Zhao B, Chua SS, Burcin MM, et al: Phenotypic consequences of lung-specific inducible expression of FGF-3. Proc Natl Acad Sci USA 98: 5898-5903, 2001.
24. Davies H, Hunter C, Smith R, et al: Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 65: 7591-7595, 2005.
25. Ogino S, Kawasaki T, Brahmandam M, et al: Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn 7: 413-421, 2005.
26. Wittwer CT, Herrmann MG, Moss AA and Rasmussen RP: Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22: 130-138, 1997.
27. Wittwer T, Ririe M, Andrew V, David A, Gungry A and Bali J: The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22: 176-181, 1997.
28. Sasaki H, Okuda K, Kawano O, et al: Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Oncol Rep 18: 623-628, 2007.
29. Krypuy M, Newnham GM, Thomas DM, Conron M and Dobrovic A: High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC Cancer 6: 295, 2006.